iSpecimen (ISPC) Short-term Investments (2023 - 2024)
iSpecimen (ISPC) posted quarterly Short-term Investments of $466493.0 for Q1 2024, down 93.57% year-over-year from $7.3 million in Q2 2023, and down 82.48% on a QoQ basis from $2.7 million in Q4 2023.
iSpecimen (ISPC) Short-term Investments (2023 - 2024) Analysis & Trends
iSpecimen (ISPC) has reported Short-term Investments for 2 consecutive years, with $466493.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Short-term Investments fell 93.57% year-over-year to $466493.0; the TTM figure through Mar 2024 stood at $466493.0 (down 93.57% YoY), while the FY2023 annual figure was $2.7 million, changed N/A from the prior year.
- Short-term Investments came in at $466493.0 for Q1 2024 at iSpecimen, down from $2.7 million in the prior quarter.
- The five-year high for Short-term Investments was $7.3 million in Q1 2023, with the low at $466493.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | iSpecimen | 931,959.22 | -1.89 Mn | -1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 466,493.00 |
| Dec 31, 2023 | 2.66 Mn |
| Sep 30, 2023 | 2.94 Mn |
| Jun 30, 2023 | 6.21 Mn |
| Mar 31, 2023 | 7.26 Mn |